Low‐dose oral isotretinoin for the treatment of adult patients with mild‐to‐moderate acne vulgaris: Systematic review and meta‐analysis
- 9 January 2022
- journal article
- review article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (4) , e15311
Abstract
Acne vulgaris is one of the most common dermatologic complaints. Recently, isotretinoin has been used as an off-label indication for the treatment of mild-to-moderate grades of acne not responding to conventional treatment. Its conventional recommended dose is 0.5-1.0 mg/kg per day to the cumulative dose of 120-150 mg/kg. Objectives To qualify the state of evidence and analyze the efficacy of the low daily dose and the pulsed doses of isotretinoin in treating mild-to-moderate acne patients with regards to response and relapse rates. Method Systematic review and meta-analysis using an electronic literature search were performed. 320 potentially relevant articles were included and reviewed. Results The level of evidence is moderate to low as conducted by the GRADE quality of evidence assessment. The pooled statistical estimate for response to treatment in the group comparing low daily doses with conventional dose showed an overall benefit for conventional dose. On the other hand, pooled data from the group comparing the low daily dose with the pulsed doses yielded an overall beneficial effect from using the low daily dose compared with the pulsed doses on achieving the response. Conclusions Given all of the available studies, the quality of evidence is low. It appears that conventional dose isotretinoin improves the odds of prolonged remission in adults with mild-to-moderate acne vulgaris compared to the low doses.Keywords
This publication has 21 references indexed in Scilit:
- Evaluation of Evidence for Acne Remission With Oral Isotretinoin Cumulative Dosing of 120-150 mg/kgJournal of Cutaneous Medicine and Surgery, 2015
- High-Dose Isotretinoin Treatment and the Rate of Retrial, Relapse, and Adverse Effects in Patients With Acne VulgarisJAMA Dermatology, 2013
- Isotretinoin 5 mg daily for low‐grade adult acne vulgaris – a placebo‐controlled, randomized double‐blind studyJournal of the European Academy of Dermatology and Venereology, 2013
- Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative studyBritish Journal of Dermatology, 2011
- Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trialIndian Journal of Dermatology, Venereology and Leprology, 2011
- Efficacy of low-dose isotretinoin in acne vulgarisIndian Journal of Dermatology, Venereology and Leprology, 2010
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Guidelines for optimal use of isotretinoin in acneJournal of the American Academy of Dermatology, 1992
- Isotretinoin therapy for acne: Results of a multicenter dose-response studyJournal of the American Academy of Dermatology, 1984
- 13-CIS RETINOIC ACID AND ACNEThe Lancet, 1980